| Molecular formula | C38H68N6O8 |
|---|
| Molecular weight | 737 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 10212452 |
|---|
What Palmitoyl Hexapeptide-12 Is
Palmitoyl hexapeptide-12 is a synthetic peptide with the molecular formula C38H68N6O8 and a molecular weight of about 737 g/mol. It has no FDA-approved label, and no drug product containing it has been reviewed for safety or effectiveness by regulators. The compound carries a PubChem entry (CID 10212452) that documents its chemical structure, but this is a chemical registry record, not evidence of any approved medical use.
Regulatory Status
Palmitoyl hexapeptide-12 is classified as an unapproved research compound. It has not been evaluated or approved by the FDA for any indication, and no clinical benefit or safety profile has been established through regulatory review.
Trial Footprint
There are currently no registered clinical trials for palmitoyl hexapeptide-12. The absence of trial data means there is no clinical evidence available from human studies to describe regarding its effects, benefits, or risks.
FAQ
No. Palmitoyl hexapeptide-12 has no FDA-approved label and is classified as an unapproved research compound. No regulatory body has reviewed it for safety or effectiveness in humans.
No clinical trials for palmitoyl hexapeptide-12 are currently registered. This means there is no published human trial data describing its effects or safety.
It is a synthetic peptide with the molecular formula C38H68N6O8 and a molecular weight of roughly 737 g/mol. Its structure is catalogued in PubChem under CID 10212452.
No adverse event reports are currently available for this compound. Because it lacks an approved label and clinical trial history, no established side effect profile exists.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 10212452
Updated 2026-09-19